newsfilter
← Latest News
Business Wire·

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

– Feedback from recent FDA interaction indicates that a confirmatory Phase 3 trial evaluating apraglutide in SBS-IF is needed to seek approval – – Company has engaged Goldman Sachs & Co. LLC to explore strategic